351.78 0.00 (0.00%)
After hours: 4:16PM EST
Previous Close | 347.71 |
Open | 340.92 |
Bid | 351.74 x 1100 |
Ask | 352.40 x 1000 |
Day's Range | 344.85 - 354.32 |
52 Week Range | 155.17 - 354.32 |
Volume | 216,378 |
Avg. Volume | 164,283 |
Market Cap | 13.582B |
Beta (5Y Monthly) | 1.12 |
PE Ratio (TTM) | 56.16 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.28 (0.37%) |
Ex-Dividend Date | Nov 13, 2020 |
1y Target Est | N/A |
Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday, February 2, 2021, at 8:00 a.m. CST to review second quarter 2021 financial results.
Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021 at 2:00 p.m. EST. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.
Bio-Techne Corporation (NASDAQ: TECH) and Regulus Therapeutics (NASDAQ: RGLS) announced a collaboration to support Regulus with biomarker analysis for the clinical development of RGLS4326, an Autosomal Dominant Polycystic Kidney Disease (ADPKD) treatment.